Fluorine-18-l-Dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography as a Tool to Localize an Insulinoma or β-Cell Hyperplasia in Adult Patients
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Context and Objective: Fluorine-18-l-dihydroxyphenylalanine (18F-DOPA) positron emission tomography (PET) is a promising method in localizing neuroendocrine tumors. Recently, it has been shown to differentiate focal forms of congenital hyperinsulinism of infancy. The current study was set up to determine the potential of 18F-DOPA PET in identifying the insulin-secreting tumors or β-cell hyperplasia of the pancreas in adults. Patients and Methods: We prospectively studied 10 patients with confirmed hyperinsulinemic hypoglycemia and presumed insulin-secreting tumor using 18F-DOPA PET. Anatomical imaging was performed with computed tomography (CT) and magnetic resonance imaging (MRI). All patients were operated on, and histological verification was available in each case. Semiquantitative PET findings in the pancreas using standardized uptake values were compared to standardized uptake values of seven consecutive patients with nonpancreatic neuroendocrine tumors. Results: By visual inspection of 18F-DOPA PET images, it was possible in nine of 10 patients to localize the pancreatic lesion, subsequently confirmed by histological analysis. 18F-DOPA uptake was enhanced in six of seven solid insulinomas and in the malignant insulinoma and its hepatic metastasis. Two patients with β-cell hyperplasia showed increased focal uptake of 18F-DOPA in the affected areas. As compared to CT or MRI, 18F-DOPA PET was more sensitive in localizing diseased pancreatic tissue. Conclusion: 18F-DOPA PET was useful in most patients with insulinoma and negative CT, MRI, and ultrasound results. In agreement with previous findings in infants, preoperative 18F-DOPA imaging seems to be a method of choice for the detection of β-cell hyperplasia in adults. It should be considered for the detection of insulinoma or β-cell hyperplasia in patients with confirmed hyperinsulinemic hypoglycemias when other diagnostic work-up is negative.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
Service, G. J., Thompson, G. B., Service, F. J., Andrews, J. C., Collazo-Clavell, M. L., & Lloyd, R. V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043690 · Cited by 779
Anlauf, M., Wieben, D., Perren, A., Sipos, B., Komminoth, P., Raffel, A., Kruse, M. L., Fottner, C., Knoefel, W. T., Mönig, H., et al. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000151617.14598.ae · Cited by 167
Nesidioblastosis associated with hyperinsulinemic hypoglycemia in adults: review of the literature
Jabri, A. L., & Bayard, C. (2004) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2004.06.012 · Cited by 56
Noninsulinoma Pancreatogenous Hypoglycemia Syndrome: A Rare Case of Adult-onset Nesidioblastosis
TSUJINO, M., SUGIYAMA, T., NISHIDA, K., TAKADA, Y., TAKANISHI, K., ISHIZAWA, M., & HIRATA, Y. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.843 · Cited by 24
Research works printed but not linked: 31
- Service, 1999, Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes., J Clin Endocrinol Metab, 84, 1582
- McAuley, 2005, Multimodality preoperative imaging of pancreatic insulinomas., Clin Radiol, 60, 1039, 10.1016/j.crad.2005.06.005 · DOI
- Grant, 2005, Insulinoma., Best Pract Res Clin Gastroenterol, 19, 783, 10.1016/j.bpg.2005.05.008 · DOI · Paper page
- Carlson, 1987, Nesidioblastosis in an adult: an illustrative case and collective review., Am J Gastroenterol, 82, 566
- Hirshberg, 2005, Malignant insulinoma: spectrum of unusual clinical features., Cancer, 104, 264, 10.1002/cncr.21179 · DOI · Paper page
- Yakovac, 1971, β-Cell nesidioblastosis in idiopathic hypoglycemia of infancy., J Pediatr, 79, 226, 10.1016/S0022-3476(71)80105-1 · DOI
- Chatziioannou, 2001, Imaging and localization of pancreatic insulinomas., Clin Imaging, 25, 275, 10.1016/S0899-7071(01)00290-X · DOI
- Eriksson, 2005, Developments in PET for the detection of endocrine tumours., Best Pract Res Clin Endocrinol Metab, 19, 311, 10.1016/j.beem.2004.11.001 · DOI
- Ericson, 1977, Accumulation of dopamine in mouse pancreatic B-cells following injection of l-DOPA. Localization to secretory granules and inhibition of insulin secretion., Diabetologia, 13, 117, 10.1007/BF00745138 · DOI
- Cegrell, 1968, The occurrence of biogenic monoamines in the mammalian endocrine pancreas., Acta Physiol Scand Suppl, 314, 1
- Ahlstrom, 1995, Pancreatic neuroendocrine tumors: diagnosis with PET., Radiology, 195, 333, 10.1148/radiology.195.2.7724749 · doi:10.1148/radiology.195.2.7724749
- Eriksson, 2002, The role of PET in localization of neuroendocrine and adrenocortical tumors., Ann NY Acad Sci, 970, 159, 10.1111/j.1749-6632.2002.tb04422.x · DOI · Paper page
- Anderson, 2001, 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors., J Nucl Med, 42, 213
- Hoegerle, 2001, Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors., Radiology, 220, 373, 10.1148/radiology.220.2.r01au25373 · DOI · Paper page
- Hoegerle, 2003, 18F-DOPA positron emission tomography for the detection of glomus tumours., Eur J Nucl Med Mol Imaging, 30, 689, 10.1007/s00259-003-1115-3 · DOI · Paper page
- Hoegerle, 2002, Pheochromocytomas: detection with 18F DOPA whole body PET—initial results., Radiology, 222, 507, 10.1148/radiol.2222010622 · DOI · Paper page
- Hoegerle, 2001, 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels., Eur J Nucl Med, 28, 64, 10.1007/s002590000404 · DOI · Paper page
- Becherer, 2004, Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET., J Nucl Med, 45, 1161
- Otonkoski, 2006, Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography., Diabetes, 55, 13, 10.2337/diabetes.55.01.06.db05-1128 · DOI · Paper page
- Ribeiro, 2005, Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-l-DOPA., J Nucl Med, 46, 560
- Hussain, 2006, The diagnosis of ectopic focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography., J Clin Endocrinol Metab, 91, 2839, 10.1210/jc.2006-0455 · DOI
- Bergman, 1994, Electrophilic synthesis of 6–18Ffuoro-L-dopa starting from aqueous-18Ffluoride., J Labelled Comp Radiopharm, 35, 476
- Boucher, 2004, Respiratory gating for 3-dimensional PET of the thorax: feasibility and initial results., J Nucl Med, 45, 214
- Gazdar, 1988, Expression of neuroendocrine cell markers l-DOPA decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin., Cancer Res, 48, 4078
- Lonlay, 2006, Congenital hyperinsulinism: pancreatic [18F]fluoro-l-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion., J Clin Endocrinol Metab, 91, 933, 10.1210/jc.2005-1713 · DOI
- Borelli, 1997, Presence of DOPA decarboxylase and its localisation in adult rat pancreatic islet cells., Diabetes Metab, 23, 161
- Kaczirek, 2004, The importance of preoperative localisation procedures in organic hyperinsulinism–experience in 67 patients., Wien Klin Wochenschr, 116, 373, 10.1007/BF03040916 · DOI
- Hirshberg, 2002, Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure., J Am Coll Surg, 194, 761, 10.1016/S1072-7515(02)01177-8 · DOI · Paper page
- Kuzin, 1998, Preoperative and intraoperative topographic diagnosis of insulinomas., World J Surg, 22, 593, 10.1007/s002689900440 · DOI
- Jaroszewski, 2004, Laparoscopic localization and resection of insulinomas., Arch Surg, 139, 270, 10.1001/archsurg.139.3.270 · DOI
- Assalia, 2004, Laparoscopic pancreatic surgery for islet cell tumors of the pancreas., World J Surg, 28, 1239, 10.1007/s00268-004-7617-8 · DOI
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Jensen, R. T., Berna, M. J., Bingham, D. B., & Norton, J. A. (2008) · Cancer · doi:10.1002/cncr.23648 · Cited by 488
Glucagon-Like Peptide-1 Receptor Imaging for Localization of Insulinomas
Christ, E., Wild, D., Forrer, F., Brändle, M., Sahli, R., Clerici, T., Gloor, B., Martius, F., Maecke, H., & Reubi, J. C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1082 · Cited by 268
Antwi, K., Fani, M., Heye, T., Nicolas, G., Rottenburger, C., Kaul, F., Merkle, E., Zech, C. J., Boll, D., Vogt, D. R., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4101-5 · Cited by 124
MANAGEMENT OF ENDOCRINE DISEASE: Pathogenesis and management of hypoglycemia
Kittah, N. E., & Vella, A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1062 · Cited by 107
Thompson, S. M., Vella, A., Thompson, G. B., Rumilla, K. M., Service, F. J., Grant, C. S., & Andrews, J. C. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2404 · Cited by 80
Innovative imaging of insulinoma: the end of sampling? A review
Christ, E., Antwi, K., Fani, M., & Wild, D. (2020) · Endocrine-Related Cancer · doi:10.1530/erc-19-0476 · Cited by 78
Diagnostic tools for post‐gastric bypass hypoglycaemia
Emous, M., Ubels, F. L., & van Beek, A. P. (2015) · Obesity Reviews · doi:10.1111/obr.12307 · Cited by 58
Dieterle, M. P., Husari, A., Prozmann, S. N., Wiethoff, H., Stenzinger, A., Röhrich, M., Pfeiffer, U., Kießling, W. R., Engel, H., Sourij, H., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061732 · Cited by 19
Hypoglycemia Controlled by Prednisone in an Occult Insulinoma or a Nesidioblastosis
Kérékou, A., El Aziz, S., Dédjan, A., Chadli, A., & Farouqi, A. (2019) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2019.96007 · Cited by 2
“Thus, Octreoscan sensibility is fifty percent and it may be coupled with single photon emission computed tomography (SCPECT-CT) [4].”
Background
Metadata
- Authors
- Kauhanen, S., Seppänen, M., Minn, H., Gullichsen, R., Salonen, A., Alanen, K., Parkkola, R., Solin, O., Bergman, J., Sane, T., Salmi, J., Välimäki, M., & Nuutila, P.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-04-01
- Volume
- 92
- Issue
- 4
- Pages
- 1237-1244
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1997869303
- Cited by
- 152
- References
- 4
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.